Neoleish

RSS

Authorised

This medicine is authorised for use in the European Union

bacterial DNA plasmid containing LACK gene from Leishmania infantum
MedicineVeterinaryAuthorised
  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

Product details

Name of medicine
Neoleish
Active substance
bacterial DNA plasmid containing LACK gene from Leishmania infantum
International non-proprietary name (INN) or common name
bacterial DNA plasmid containing LACK gene from Leishmania infantum

Pharmacotherapeutic group

  • Immunologicals for canidae
  • Other immunologicals

Authorisation details

EMA product number
EMEA/V/C/005538

Assessment history

This page was last updated on

Share this page